Frankie Bones in Hilton Head Island, South Carolina, serves up a perfectly cooked, flavor-packed cut of beef that you won’t ...

In a move that blurs the line between science fiction and reality, Colossal Biosciences, the pioneering de-extinction company backed by countless celebs, has secured $200 million in Series C funding.

Colossal Biosciences – the company behind an ambitious, Jurassic Park-style effort to revive extinct bird and mammal species such as the thylacine, dodo and woolly mammoth – said it had raised ...

Colossal Biosciences, the company that’s famously on a mission to bring back the woolly mammoth and two other extinct species, has raised a $200 million Series C at a $10.2 billion valuation ...

From my bedroom, I watched the sun sink behind a neighboring island one night and paint a neon pink stripe in the sky. The phenomenon means that days seem to last forever. They blur into one and ...

Learn More Colossal BioSciences has raised $200 million in a new round of funding to bring back extinct species like the woolly mammoth. Dallas- and Boston-based Colossal is making strides in the ...

Colossal has also altered the DNA sequence in chicken primordial germ cells (PGCs), injected them into embryos, and successfully hatched chimeric chicks. Their offspring will be surrogates for dodos.

Dallas-based Colossal has put itself into a unique class of businesses: a decacorn. There are only 75 such privately-held companies—those holding a valuation of $10 billion or more—on the ...

DALLAS--(BUSINESS WIRE)--Colossal Biosciences, the world’s first de-extinction company, has today announced $200M in a Series C financing by TWG Global, a diversified holding company with ...

The NFL has systematically developed the Super Bowl into one of the greatest yearly entertainment spectacles, and it isn't just because of the on-field action. Sure, many NFL fans tune in to watch ...